Abudurexiti M - Search Results

1

The function and mechanisms of action of circular RNAs in Urologic Cancer.

Zhang ZH, Wang Y, Zhang Y, Zheng SF, Feng T, Tian X, Abudurexiti M, Wang ZD, Zhu WK, Su JQ, Zhang HL, Shi GH, Wang ZL, Cao DL, Ye DW. Zhang ZH, et al. Among authors: abudurexiti m. Mol Cancer. 2023 Mar 25;22(1):61. doi: 10.1186/s12943-023-01766-2. Mol Cancer. 2023. PMID: 36966306 Free PMC article. Review.

2

The U Shape of Prostate-specific Antigen and Prostate Cancer-specific Mortality in High-grade Metastatic Prostate Adenocarcinoma.

Wang J, Abudurexiti M, Shao N, Wei Y, Zhu Y, Ye DW. Wang J, et al. Among authors: abudurexiti m. Eur Urol Focus. 2020 Jan 15;6(1):53-62. doi: 10.1016/j.euf.2018.08.024. Epub 2018 Sep 11. Eur Urol Focus. 2020. PMID: 30217630

3

Prognosis of rare pathological primary urethral carcinoma.

Abudurexiti M, Wang J, Shao N, Wan FN, Zhu Y, Dai B, Ye DW. Abudurexiti M, et al. Cancer Manag Res. 2018 Dec 7;10:6815-6822. doi: 10.2147/CMAR.S184197. eCollection 2018. Cancer Manag Res. 2018. PMID: 30584373 Free PMC article.

4

Causes of Death and Conditional Survival of Renal Cell Carcinoma.

Shao N, Wan F, Abudurexiti M, Wang J, Zhu Y, Ye D. Shao N, et al. Among authors: abudurexiti m. Front Oncol. 2019 Jul 15;9:591. doi: 10.3389/fonc.2019.00591. eCollection 2019. Front Oncol. 2019. PMID: 31380266 Free PMC article.

5

Decreased SPTLC1 expression predicts worse outcomes in ccRCC patients.

Zhu WK, Xu WH, Wang J, Huang YQ, Abudurexiti M, Qu YY, Zhu YP, Zhang HL, Ye DW. Zhu WK, et al. Among authors: abudurexiti m. J Cell Biochem. 2020 Feb;121(2):1552-1562. doi: 10.1002/jcb.29390. Epub 2019 Sep 12. J Cell Biochem. 2020. PMID: 31512789

6

Development and External Validation of a Novel 12-Gene Signature for Prediction of Overall Survival in Muscle-Invasive Bladder Cancer.

Abudurexiti M, Xie H, Jia Z, Zhu Y, Zhu Y, Shi G, Zhang H, Dai B, Wan F, Shen Y, Ye D. Abudurexiti M, et al. Front Oncol. 2019 Sep 6;9:856. doi: 10.3389/fonc.2019.00856. eCollection 2019. Front Oncol. 2019. PMID: 31552180 Free PMC article.

7

Prognosis of Patients With Testicular Carcinoma Is Dependent on Metastatic Site.

Xu P, Wang J, Abudurexiti M, Jin S, Wu J, Shen Y, Ye D. Xu P, et al. Among authors: abudurexiti m. Front Oncol. 2020 Jan 10;9:1495. doi: 10.3389/fonc.2019.01495. eCollection 2019. Front Oncol. 2020. PMID: 31998648 Free PMC article.

8

GLUT1 is an AR target contributing to tumor growth and glycolysis in castration-resistant and enzalutamide-resistant prostate cancers.

Wang J, Xu W, Wang B, Lin G, Wei Y, Abudurexiti M, Zhu W, Liu C, Qin X, Dai B, Wan F, Zhang H, Zhu Y, Ye D. Wang J, et al. Among authors: abudurexiti m. Cancer Lett. 2020 Aug 10;485:45-55. doi: 10.1016/j.canlet.2020.05.007. Epub 2020 May 16. Cancer Lett. 2020. PMID: 32428663

9

Targeting CPT1B as a potential therapeutic strategy in castration-resistant and enzalutamide-resistant prostate cancer.

Abudurexiti M, Zhu W, Wang Y, Wang J, Xu W, Huang Y, Zhu Y, Shi G, Zhang H, Zhu Y, Shen Y, Dai B, Wan F, Lin G, Ye D. Abudurexiti M, et al. Prostate. 2020 Sep;80(12):950-961. doi: 10.1002/pros.24027. Epub 2020 Jul 10. Prostate. 2020. PMID: 32648618

10

Locoregional surgical treatment improves the prognosis in patients with primary metastatic testicular cancer with a single bone or brain metastasis.

Abudurexiti M, Zhu Y, Ye DW. Abudurexiti M, et al. Mol Clin Oncol. 2020 Aug;13(2):146-154. doi: 10.3892/mco.2020.2057. Epub 2020 Jun 3. Mol Clin Oncol. 2020. PMID: 32714538 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page